How many clinical trials are tracked of cariprazine?

19 trials are tracked, 11 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

cariprazine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of cariprazine

19 trials tracked of cariprazine: 14 in phase 3 or 4 and 11 with published results. The most-cited published study has 168 citations.

19Trials tracked

14Phase 3 & 4

0Recruiting

11With published results

Phase distribution

Phase 3 14 Phase 2 5

Phase 3 Safety and Efficacy of Cariprazine in Patients With Schizophrenia Completed · 168 cited
Phase 3 Safety and Efficacy of Cariprazine for Bipolar I Disorder Completed · 119 cited
Phase 3 A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia Completed · 100 cited
Phase 3 Long-term Study of Cariprazine in Patients With Schizophrenia Completed · 84 cited
Phase 3 Safety and Efficacy of Cariprazine in Schizophrenia Completed · 69 cited
Phase 3 Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone Completed · 57 cited

Show 13 more trials

Phase 3 Safety and Efficacy of Cariprazine for Mania Completed · 40 cited
Phase 3 Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder Completed · 36 cited
Phase 3 Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression Completed · 29 cited
Phase 3 Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder Completed · 29 cited
Phase 3 The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone Completed · 21 cited
Phase 3 Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder Completed
Phase 3 Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Completed
Phase 3 A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features Completed
Phase 2 Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression Completed
Phase 2 Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia Completed
Phase 2 Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression Completed
Phase 2 Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder Completed
Phase 2 A Study of Cariprazine in Patients With Chronic Stable Schizophrenia Completed

Showing the 19 most-cited and recently-updated of 19 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.